Avania

We are happy to announce that Avania has acquired anagram, a leading MedTech CRO in Spain. This acquisition expands our full-service capabilities while adding a key presence in Southern Europe. We can now further serve clients across new geographies with enhanced subject matter expertise in cardiology, neurology, and oncology. We’re stronger together, and we’re excited to help advance the future of medical technology with even greater scale and stronger end-to-end support. Read our press release for more.     When you need a truly global partner to advance your MedTech, It Takes Avania. https://lnkd.in/grAtQeps #MedTech #MedDevice #ItTakesAvania

From time savings to global coverage, there are many reasons to consider outsourcing your regulatory and medical writing. Dive deeper into these benefits, and how Avania can support your #MedTech. Read it now: https://ow.ly/QMKa50UfoJT #MedicalWriting #ItTakesAvania

December is a time when many cultures honor diverse traditions. However you celebrate, Avania wishes you happy holidays!  

How does Avania address the #MedTech industry’s evolving needs? In this Medical Device News Magazine article, our CEO, Jason Monteleone, shares his insights into Avania’s vision and strategy with an overview of the current state of the #CRO industry. Read now to discover how we help bring life-changing technology to market. https://lnkd.in/ezNdP7re  

Diversity, inclusion, and #MedTech sustainability are deeply embedded in our culture at Avania. Through various initiatives, we strive to have a positive impact on our patients, stakeholders, the planet, and the communities we operate in. Learn more about our values and commitments. https://ow.ly/KcVT50Ufp7H #Sustainability #Inclusion #ItTakesAvania

#AI integration continues to transform #MedTech. This article explores common uses of AI, challenges for adoption, and future potential for evolution. Check it out, then let us know what you think in the comments. https://ow.ly/6goO50UfpfE #MedDevice

As digital technology becomes increasingly complex, definitions for reimbursement have often not caught up to the latest capabilities. Variations in coverage, coding, and payment systems across countries create additional considerations. In a recent webinar, Avania’s Sr. Vice President of Market Access, Stephen Hull, shares his perspectives on global strategies, with a focus on the U.S., France, Germany, and the U.K. Watch the replay now: https://lnkd.in/e2sV46tm  #DigitalHealth #MedTech #ItTakesAvania

If there’s a sudden industry shift and you need to update your #MedTech, how can you adjust your trial approach? Adaptive clinical study design could be the answer. In this white paper, we share expert insights into how adaptive design works, its benefits and limitations, and tips for making the most of this strategy. Download your copy today. https://ow.ly/WYlT50UfnJf #ClinicalTrials #ItTakesAvania

At Avania, our commitment to improving the #MedTech space goes beyond innovation—we’re here to support the developers and pioneers shaping the future of healthcare. Through strategic partnerships, we help emerging innovators bring their ideas to life. Discover how we’re advancing the industry and supporting the next generation of MedTech solutions. https://ow.ly/fWUL50Ufp4K #Innovation #ItTakesAvania

Prepare for tougher EU medical device regulation (MDR) standards with Avania. As an end-to-end MedTech CRO, we ease your process with tailored solutions, in-depth knowledge, and a full range of support. Learn how to streamline your EU MDR compliance. https://ow.ly/NB5N50UfmXj #MedTech #CRO #MDRCompliance